Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $1.951B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRAX | PRAXIS PRECISION MEDICINES I | 640,000 | $214M | 11.0% | — | — | COM NEW | 74006W207 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 17,878,594 | $136M | 7.0% | — | — | COM NEW | 107924102 |
| PBLS | PARABILIS MEDICINES INC | 4,615,612 | $126M | 6.5% | — | — | COM | 698955101 |
| RAPP | RAPPORT THERAPEUTICS INC | 2,657,521 | $111M | 5.7% | — | — | COM | 75383L102 |
| ERAS | ERASCA INC | 6,000,000 | $110M | 5.6% | — | — | COM | 29479A108 |
| EWTX | EDGEWISE THERAPEUTICS INC | 2,510,000 | $102M | 5.2% | — | — | COM | 28036F105 |
| EYPT | EYEPOINT INC | 7,000,000 | $100M | 5.1% | — | — | COM NEW | 30233G209 |
| ALMS | ALUMIS INC | 3,285,596 | $92.46M | 4.7% | — | — | COM | 022307102 |
| ABVX | ABIVAX SA | 675,000 | $89.95M | 4.6% | — | — | SPONSORED ADS | 00370M103 |
| DNTH | DIANTHUS THERAPEUTICS INC | 750,000 | $73.11M | 3.7% | — | — | COM | 252828108 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 900,000 | $63.18M | 3.2% | — | — | COM NEW | 10919W405 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 3,205,433 | $62.41M | 3.2% | — | — | CLASS A ORD | 61559X104 |
| BIOA | BIOAGE LABS INC | 2,390,605 | $58.59M | 3.0% | — | — | COM | 09077V100 |
| ORKA | ORUKA THERAPEUTICS INC | 533,340 | $50.76M | 2.6% | — | — | COM | 687604108 |
| ANL | ADLAI NORTYE LTD | 3,978,229 | $45.75M | 2.3% | — | — | SPONSORED ADS | 00704R109 |
| BBIO | BRIDGEBIO PHARMA INC | 550,000 | $40.96M | 2.1% | — | — | COM | 10806X102 |
| TNGX | TANGO THERAPEUTICS INC | 1,300,000 | $40.64M | 2.1% | — | — | COM | 87583X109 |
| BHVN | BIOHAVEN LTD | 2,610,000 | $38.84M | 2.0% | — | — | COM | G1110E107 |
| AGMB | AGOMAB THERAPEUTICS NV | 2,465,348 | $32M | 1.6% | — | — | SPONSORED ADS | 00860C102 |
| MBX | MBX BIOSCIENCES INC | 550,000 | $30.36M | 1.6% | — | — | COM | 55287L101 |
| CLYM | CLIMB BIO INC | 2,106,000 | $27.46M | 1.4% | — | — | COM | 28658R106 |
| OLMA | OLEMA PHARMACEUTICALS INC | 2,150,000 | $26.9M | 1.4% | — | — | COM | 68062P106 |
| GLTO | DAMORA THERAPEUTICS INC | 1,000,000 | $26.01M | 1.3% | — | — | COM | 36322Q206 |
| PHVS | PHARVARIS N V | 750,000 | $25.93M | 1.3% | — | — | COM | N69605108 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 2,344,971 | $22M | 1.1% | — | — | COM NEW | 21833P301 |
| SYRE | SPYRE THERAPEUTICS INC | 225,000 | $19.98M | 1.0% | — | — | COM NEW | 00773J202 |
| DFTX | DEFINIUM THERAPEUTICS INC | 400,000 | $18.82M | 1.0% | — | — | COM SHS | 24477V105 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 500,000 | $16.95M | 0.9% | — | — | ORDINARY SHARES | N62509109 |
| ROIV | ROIVANT SCIENCES LTD | 475,000 | $16.81M | 0.9% | — | — | SHS | G76279101 |
| CABA | CABALETTA BIO INC | 5,000,000 | $15.55M | 0.8% | — | — | COM | 12674W109 |
| HLXC | HELIX ACQUISITION CORP III | 1,297,500 | $13.81M | 0.7% | — | — | USD CL A ORD SHS | G4444S107 |
| ASND | ASCENDIS PHARMA A/S | 50,000 | $13.34M | 0.7% | — | — | ORD SHS | K08588103 |
| KLRA | KAILERA THERAPEUTICS INC | 550,000 | $12.12M | 0.6% | — | — | COMMON STOCK | 482931102 |
| INSM | INSMED INC | 75,000 | $7.997M | 0.4% | — | — | COM PAR $.01 | 457669307 |
| SNSE | FAETH THERAPEUTICS INC | 1,028,242 | $7.656M | 0.4% | — | — | COM NEW | 81728A207 |
| ELVN | ENLIVEN THERAPEUTICS INC | 150,000 | $7.612M | 0.4% | — | — | COM | 29337E102 |
| TARS | TARSUS PHARMACEUTICALS INC | 100,000 | $6.294M | 0.3% | — | — | COM | 87650L103 |
| IBIO | IBIO INC | 3,570,000 | $6.247M | 0.3% | — | — | COM NEW | 451033708 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 125,000 | $4.678M | 0.2% | — | — | COM | 22663K107 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 175,000 | $4.588M | 0.2% | — | — | COM | 03969K108 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 50,000 | $4.075M | 0.2% | — | — | COM | 04280A100 |
| GPCR | STRUCTURE THERAPEUTICS INC | 75,000 | $4.025M | 0.2% | — | — | SPONSORED ADS | 86366E106 |
| RACC | RESEARCH ALLIANCE CORP III | 370,000 | $3.959M | 0.2% | — | — | ORD SHS CL A | G75226103 |
| COGT | COGENT BIOSCIENCES INC | 100,000 | $3.87M | 0.2% | — | — | COM | 19240Q201 |
| ALT | ALTIMMUNE INC | 1,250,000 | $3.8M | 0.2% | — | — | COM NEW | 02155H200 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 200,000 | $3.592M | 0.2% | — | — | COM | 03237H101 |
| ODTX | ODYSSEY THERAPEUTICS INC | 175,000 | $3.274M | 0.2% | — | — | COMMON STOCK | 67613T104 |
| PCVX | VAXCYTE INC | 50,000 | $2.906M | 0.1% | — | — | COM | 92243G108 |
| BOLD | BOUNDLESS BIO INC | 1,000,000 | $2.5M | 0.1% | — | — | COM | 10170A100 |
| QNCX | QUINCE THERAPEUTICS INC | 5,498 | $100K | 0.0% | — | — | COM | 22053A305 |